CCP
TEVA icon

Clough Capital Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Clough Capital Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,600
Closed -$353K – 237
2016
Q1 		$353K Buy
+6,600
New +$387K 0.02% 180
2014
Q2 		– Sell
-340,100
Closed -$18M – 220
2014
Q1 		$18M Buy
+340,100
New +$15.7M 0.56% 70

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Clough Capital Partners's TEVA Position: Q2 2016 in Review

Clough Capital Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2016, closing a stake of 6,600 shares — an estimated $353K sold.

Clough Capital Partners first reported a position in TEVA in Q1 2014 and held it in 2 quarters. The position peaked at $18M in Q1 2014. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Clough Capital Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2016 after selling out during the quarter.
  • Clough Capital Partners sold 6,600 Teva Pharmaceutical Industries Limited shares in Q2 2016, an estimated $353K.
  • Clough Capital Partners first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and held it in 2 quarters.
  • Clough Capital Partners's Teva Pharmaceutical Industries Limited position peaked at $18M in Q1 2014.
  • 813 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2016.

Based on Clough Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.